 A medical worker takes COVID-19 testing samples in Bangkok, Thailand. (Photo: AFP/VNA) |
The US company Pfizer announced that it has started clinical trials of the SARS-CoV-2 antiviral drug PF-07321332’s.
The primary objective is to assess the treatment’s safety and efficacy for the prevention of confirmed SARS-CoV-2 infection and its symptoms through Day 14.